{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-025926","form_type":"8-K","ticker":"OVID","cik":"0001636651","company_name":"Ovid Therapeutics Inc.","filed_at":"2026-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.634642+00:00","generated_at":"2026-05-15T05:20:04.320975+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Ovid Therapeutics receives $53.9M from exercise of Series A warrants; issues 33.6M common shares","bullets":["Series A warrants from Oct 2025 private placement expired on April 17, 2026; 38,481,325 underlying shares.","Investors exercised 33,597,860 shares at $1.40 each and 4,883,464 pre-funded warrants at $1.399 each.","Gross proceeds of approximately $53.9 million to the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-025926","json":"https://secwatch.observer/filing/0001628280-26-025926.json","markdown":"https://secwatch.observer/filing/0001628280-26-025926.md","text":"https://secwatch.observer/filing/0001628280-26-025926.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636651/000162828026025926/0001628280-26-025926-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636651/000162828026025926/ovid-20260420.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:20:04.320975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}